IF YOU THINK RESEARCH IS EXPENSIVE...TRY DISEASE. Trademark

Trademark Overview

On Thursday, May 11, 2017, a trademark application was filed for IF YOU THINK RESEARCH IS EXPENSIVE...TRY DISEASE. with the United States Patent and Trademark Office. The USPTO has given the IF YOU THINK RESEARCH IS EXPENSIVE...TRY DISEASE. trademark a serial number of 87445729. The federal status of this trademark filing is REGISTERED as of Tuesday, January 15, 2019. This trademark is owned by Albert and Mary Lasker Foundation. The IF YOU THINK RESEARCH IS EXPENSIVE...TRY DISEASE. trademark is filed in the Advertising, Business and Retail Services category with the following description:

Public advocacy to promote awareness of the need to support medical research concerning the understanding, diagnosis, treatment and prevention of disease
if you think research is expensive...try disease.

General Information

Serial Number87445729
Word MarkIF YOU THINK RESEARCH IS EXPENSIVE...TRY DISEASE.
Filing DateThursday, May 11, 2017
Status700 - REGISTERED
Status DateTuesday, January 15, 2019
Registration Number5656627
Registration DateTuesday, January 15, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Goods and ServicesPublic advocacy to promote awareness of the need to support medical research concerning the understanding, diagnosis, treatment and prevention of disease

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code035
First Use Anywhere DateMonday, April 24, 2017
First Use In Commerce DateMonday, April 24, 2017

Trademark Owner History

Party NameAlbert and Mary Lasker Foundation
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNew York, NY 10174
Party NameAlbert and Mary Lasker Foundation
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10174
Party NameAlbert and Mary Lasker Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10174

Trademark Events

Event DateEvent Description
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Friday, December 14, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 13, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 10, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018SU - NON-FINAL ACTION - WRITTEN
Thursday, August 23, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 26, 2018USE AMENDMENT FILED
Wednesday, August 22, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 26, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 1, 2018ASSIGNED TO LIE
Tuesday, January 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 15, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 15, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 9, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 15, 2017NEW APPLICATION ENTERED

Related Keywords

disease expensive research think understanding concerning diagnosis treatment prevention medical promote advocacy